Sign Up to like & get
recommendations!
0
Published in 2017 at "Rheumatology International"
DOI: 10.1007/s00296-017-3828-9
Abstract: Previous research has shown that diabetes mellitus increases the risk of lower extremity amputation in patients with peripheral arterial occlusive disease. However, to our knowledge, no studies have investigated whether systemic autoimmune disease, in particular…
read more here.
Keywords:
extremity amputation;
lower extremity;
risk lower;
disease ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2020.1840340
Abstract: Abstract Aims and background Sodium-glucose cotransporter-2 (SGLT2) inhibitor has been linked to an increased risk of lower extremity amputation (LEA) in patients with Type 2 Diabetes (T2D) and is known to induce volume depletion through…
read more here.
Keywords:
amputation;
risk lower;
risk;
lower extremity ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2018 at "Pediatrics"
DOI: 10.1542/peds.2018-2420mmm
Abstract: HT den Dekker, VWV Jaddoe, IK Reiss, JC de Jongste, L Duijts. Am J Respir Crit Care Med. 2018;197(2):183–192 Low birth weight has been associated with increased risk of asthma symptoms. The purpose of this…
read more here.
Keywords:
risk lower;
infant growth;
growth patterns;
patterns risk ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Diabetes"
DOI: 10.2337/db19-67-or
Abstract: Recently, an increased risk of lower extremity amputation (LEA) was observed with canagliflozin, a SGLT2 inhibitor, in the CANVAS trial although observational studies showed conflicting results. This association could be related to the contraction of…
read more here.
Keywords:
lea;
risk lower;
type diabetes;
copeptin ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Diabetes care"
DOI: 10.2337/dc21-2638
Abstract: OBJECTIVE Patients with diabetes have an increased risk for lower-limb amputation (LLA), but biomarkers to assess risk of LLA are lacking. Adrenomedullin (ADM) is a vasodilator peptide that also plays a role in fluid and…
read more here.
Keywords:
risk lower;
people type;
lla;
risk ... See more keywords